Save

Safety evaluation of Lactiplantibacillus plantarum N13: genomic, phenotypic, and toxicological assessment for probiotic applications

in Beneficial Microbes
Autor:innen:
Y. Qi Department of Research and Development, Henan ANIMIC Biotechnology Co., Ltd., Luohe, 462000, China

Search for other papers by Y. Qi in
Current site
Google Scholar
PubMed
Close
,
W. Si Department of Research and Development, Henan ANIMIC Biotechnology Co., Ltd., Luohe, 462000, China

Search for other papers by W. Si in
Current site
Google Scholar
PubMed
Close
,
Y. Fan Department of Research and Development, Henan ANIMIC Biotechnology Co., Ltd., Luohe, 462000, China

Search for other papers by Y. Fan in
Current site
Google Scholar
PubMed
Close
,
Y. Dong Department of Research and Development, Henan ANIMIC Biotechnology Co., Ltd., Luohe, 462000, China

Search for other papers by Y. Dong in
Current site
Google Scholar
PubMed
Close
https://orcid.org/0000-0002-4425-3793
,
Z. Gai Department of Research and Development, Henan ANIMIC Biotechnology Co., Ltd., Luohe, 462000, China

Search for other papers by Z. Gai in
Current site
Google Scholar
PubMed
Close
, und
Y. Zhang Department of Food Quality and Safety, Shanghai Business School, Shanghai 200235, China

Search for other papers by Y. Zhang in
Current site
Google Scholar
PubMed
Close
Zitierung herunterladen Berechtigungen erhalten

Optionen für den Zugriff

Nutzen Sie bitte eine der untenstehenden Zugriffsmöglichkeiten, um den vollständigen Artikel zu lesen.

Institutszugang

Melden Sie sich mit Open Athens, Shibboleth oder Ihren institutionellen Anmeldedaten an.

Über Institut einloggen

Kauf

Sofortzugang erwerben (PDF-Download und unbegrenzter Online-Zugang):

36,93 €

Weitere Zugriffsmöglichkeiten

Auf DeepDyve mieten
Token einlösen

Abstract

Probiotics offer numerous health benefits and are increasingly incorporated into dietary supplements and food products. Rigorous safety evaluations are essential to ensure their suitability for human consumption. This study evaluates the safety profile of Lactiplantibacillus plantarum N13, isolated from traditional fermented dairy products, through genomic and phenotypic analyses. Whole-genome sequencing confirmed general length of strain N13 (containing three plasmids) is about 3,318,516 bp, GC content is 44.4% and the absence of antibiotic resistance and virulence genes. Antibiotic susceptibility tests demonstrated that N13 is sensitive to ampicillin (1 μg/ml), gentamycin (4 μg/ml), kanamycin (32 μg/ml), erythromycin (0.5 μg/ml), clindamycin (0.25 μg/ml), tetracycline (32 μg/ml), and chloramphenicol (8 μg/ml), meeting the European Food Safety Authority (EFSA) guidelines. Additionally, genome analysis confirmed that N13 lacks genes related to biogenic amine biosynthesis, indicating its low risk of biogenic amine production. Scanning electron microscopy confirmed that N13 cells exhibited typical L. plantarum morphology. Phenotypic assays demonstrated that N13 is non-hemolytic and lacks harmful enzyme activity, including α-galactosidase, β-glucuronidase, and α-mannosidase. Acute and 28-day oral toxicity tests demonstrated that N13 was well tolerated in both Immunocompetent Research mice and Sprague Dawley rats, with no observable toxic effects or adverse changes even at high doses. At the recommended dose (0.5 × 1010 CFU/kg), N13 exhibited good oral safety. These findings establish L. plantarum N13 as a safe and promising probiotic strain, paving the way for its further application in dietary and functional food products.

Kennzahlen

Insgesamt Letzte 365 Tage In den letzten 30 Tagen
Aufrufe von Kurzbeschreibungen 324 319 53
Gesamttextansichten 21 21 1
PDF-Downloads 42 42 2